시장보고서
상품코드
1796120

치과 감염증 치료 시장 규모, 점유율, 성장 분석 : 치료 유형별, 감염증 유형별, 최종사용자별, 지역별 - 산업 예측(2025-2032년)

Dental Infection Treatment Market Size, Share, and Growth Analysis, By Treatment Type (Antibiotics, Antifungals), By Infection Type (Periodontal Infections, Endodontic Infections), By End-Users, By Region - Industry Forecast 2025-2032

발행일: | 리서치사: SkyQuest | 페이지 정보: 영문 184 Pages | 배송안내 : 3-5일 (영업일 기준)

    
    
    



※ 본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문 목차를 참고해주시기 바랍니다.

세계의 치과 감염증 치료 시장 규모는 2023년에 124억 8,000만 달러로 평가되며, 2024년에는 136억 4,000만 달러, 2032년에는 277억 8,000만 달러로 성장하며, 예측 기간(2025-2032년)의 CAGR은 9.30%로 성장할 전망입니다.

세계 치과 감염 치료 시장은 주로 치주염, 충치, 치내 감염과 같은 치과 질환의 유병률 증가로 인해 괄목할 만한 성장세를 보이고 있습니다. 구강 위생에 대한 인식이 높아지고, 치아에 문제가 생기기 쉬운 고령층이 늘어나면서 효과적인 치료 옵션에 대한 수요가 증가하고 있습니다. 저침습적 시술과 혁신적인 항균 전략을 포함한 진단 및 치료 방법의 기술 발전은 이러한 성장을 더욱 촉진하고 있습니다. 그러나 첨단 치료에 따른 고비용, 개발도상국에서의 제한된 접근성, 미흡한 치과 보험 적용 등이 여전히 과제로 남아있습니다. 또한 병원균의 항균제 내성이 증가함에 따라 치료의 지속적인 기술 혁신이 필요합니다. 환자 진단 및 모니터링에서 AI와 IoT의 통합은 이 시장에서 조기 발견을 개선하고 환자 치료를 강화할 수 있는 기회를 제공합니다.

목차

서론

  • 분석 목적
  • 시장 범위
  • 정의

분석 방법

  • 정보 조달
  • 2차·1차 데이터 방법
  • 시장 규모 예측
  • 시장 상정과 제약

개요

  • 시장 개요와 전망
  • 수급 동향 분석
  • 부문별 기회 분석

시장 역학과 전망

  • 시장 개요
  • 시장 규모
  • 시장 역학
    • 촉진요인과 기회
    • 억제요인과 과제
  • Porter의 산업 분석

시장의 주요 인사이트

  • 주요 성공 요인
  • 경쟁의 정도
  • 주요 투자 기회
  • 시장 에코시스템
  • 시장의 매력 지수(2024년)
  • PESTEL 분석
  • 거시경제 지표
  • 밸류체인 분석
  • 가격 분석
  • 기술 진보
  • 사례 연구
  • 고객과 구매 기준 분석

세계의 치과 감염증 치료 시장 규모·CAGR : 치료 유형별(2025-2032년)

  • 시장 개요
  • 항생제
  • 항진균제
  • 항바이러스제
  • 통증 관리
  • 외과 시술(치내요법, 발치)
  • 외용약

세계의 치과 감염증 치료 시장 규모·CAGR : 감염증 유형별(2025-2032년)

  • 시장 개요
  • 치주감염증(치은염, 치주염)
  • 치내 감염증(치수염, 농양)
  • 충치 관련 감염증
  • 치관주위염
  • 구강 칸디다증

세계의 치과 감염증 치료 시장 규모·CAGR : 최종사용자별(2025-2032년)

  • 시장 개요
  • 치과의원
  • 병원
  • 외래 수술 센터
  • 연구·학술기관

세계의 치과 감염증 치료 시장 규모·CAGR(2025-2032년)

  • 북미
    • 미국
    • 캐나다
  • 유럽
    • 독일
    • 스페인
    • 프랑스
    • 영국
    • 이탈리아
    • 기타 유럽
  • 아시아태평양
    • 중국
    • 인도
    • 일본
    • 한국
    • 기타 아시아태평양
  • 라틴아메리카
    • 브라질
    • 기타 라틴아메리카
  • 중동 및 아프리카
    • GCC 국가
    • 남아프리카공화국
    • 기타 중동 및 아프리카

경쟁 구도

  • 상위 5사의 비교
  • 주요 기업의 시장 포지셔닝(2024년)
  • 주요 기업이 채택한 전략
  • 시장의 최근 동향
  • 주요 기업의 시장 점유율(2024년)
  • 주요 기업의 개요
    • 기업 개요
    • 제품 포트폴리오 분석
    • 부문별 점유율 분석
    • 매출의 전년대비 비교(2022-2024년)

주요 기업 개요

  • Patterson Dental Supply, Inc.(미국)
  • Johnson & Johnson(미국)
  • Pfizer Inc.(미국)
  • Kerr Corporation(미국)
  • Bristol-Myers Squibb(미국)
  • Septodont Healthcare India Pvt. Ltd.(인도)
  • Henry Schein, Inc.(미국)
  • Ultradent Products Inc.(미국)
  • Endo Pharmaceuticals(미국)
  • Taj Pharmaceuticals Limited(인도)
  • Daiichi Sankyo(일본)
  • Bayer HealthCare(독일)
  • Young Innovations, Inc.(미국)
  • 3 M(미국)
  • A-dec Inc.(미국)
  • Dentsply Sirona Inc.(미국)
  • COLTENE Group(스위스)
  • Getinge AB(스웨덴)
  • GC America Inc.(미국)

결론과 제안

KSA 25.08.29

Global Dental Infection Treatment Market size was valued at USD 12.48 Billion in 2023 poised to grow between USD 13.64 Billion in 2024 to USD 27.78 Billion by 2032, growing at a CAGR of 9.30% in the forecast period (2025-2032).

The global dental infection treatment market is experiencing notable growth driven primarily by the increasing prevalence of dental diseases such as periodontitis, caries, and endodontic infections. Heightened awareness of oral hygiene, along with an aging demographic prone to dental issues, fuels demand for effective treatment options. Technological advancements in diagnostics and treatment methodologies, including minimally invasive procedures and innovative antimicrobial strategies, further bolster this growth. However, challenges persist due to the high costs associated with advanced treatments, limited accessibility in developing regions, and inadequate dental insurance coverage. Additionally, rising antimicrobial resistance among pathogens necessitates ongoing innovations in treatment. The integration of AI and IoT in patient diagnostics and monitoring presents opportunities for improving early detection and enhancing patient care in this market.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Dental Infection Treatment market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Dental Infection Treatment Market Segments Analysis

The global dental infection treatment market is segmented based on treatment type, infection type, end-user, and region. In terms of treatment type, the market is divided into antibiotics, antifungals, antivirals, pain management, surgical procedures, and topical medications. Based on infection type, the market is bifurcated into periodontal infections, endodontic infections, caries-related infections, pericoronitis, and oral candidiasis. Based on end-user, the market is grouped into dental clinics, hospitals, ambulatory surgical centres, and research & academic institutions. Based on region, the market is segmented into North America, Europe, Asia-Pacific, Latin America, and the Middle East and Africa.

Driver of the Global Dental Infection Treatment Market

One key market driver for the global dental infection treatment market is the rising prevalence of dental diseases and infections, largely attributed to poor oral hygiene, unhealthy dietary habits, and a lack of awareness about dental care. As more individuals experience conditions such as periodontitis, dental abscesses, and endodontic infections, the demand for effective treatment options increases. This growing incidence of dental infections not only necessitates advancements in treatment technologies and pharmaceuticals but also fosters a greater emphasis on preventive care and public awareness campaigns, thus propelling the overall market for dental infection treatment solutions worldwide.

Restraints in the Global Dental Infection Treatment Market

One significant market restraint for the global dental infection treatment market is the rising prevalence of antibiotic resistance. As more bacteria develop resistance to commonly used antibiotics, the effectiveness of traditional treatments is compromised, leading to challenges in managing dental infections. This growing issue not only affects patient outcomes but also complicates treatment protocols for dental professionals. Additionally, the increasing awareness and caution among healthcare providers regarding the over-prescription of antibiotics may limit the adoption of necessary medical interventions. Consequently, the need for alternative treatment options and effective infection control measures becomes paramount, impacting the market's growth potential.

Market Trends of the Global Dental Infection Treatment Market

The global dental infection treatment market is experiencing a significant transformation driven by the integration of digital dentistry and AI-powered diagnostic solutions. These advancements facilitate enhanced imaging capabilities and streamline diagnostic processes, enabling clinicians to identify and address infections more promptly and effectively. As a result, personalized treatment plans are emerging, tailored to individual patient needs, which improves both diagnostic accuracy and overall health outcomes. Furthermore, the adoption of these innovative technologies enhances clinical workflows, fosters greater efficiency in dental practices, and sets the stage for ongoing innovations, underscoring a dynamic shift in how dental infections are diagnosed and treated worldwide.

Table of Contents

Introduction

  • Objectives of the Study
  • Scope of the Report
  • Definitions

Research Methodology

  • Information Procurement
  • Secondary & Primary Data Methods
  • Market Size Estimation
  • Market Assumptions & Limitations

Executive Summary

  • Global Market Outlook
  • Supply & Demand Trend Analysis
  • Segmental Opportunity Analysis

Market Dynamics & Outlook

  • Market Overview
  • Market Size
  • Market Dynamics
    • Drivers & Opportunities
    • Restraints & Challenges
  • Porters Analysis
    • Competitive rivalry
    • Threat of substitute
    • Bargaining power of buyers
    • Threat of new entrants
    • Bargaining power of suppliers

Key Market Insights

  • Key Success Factors
  • Degree of Competition
  • Top Investment Pockets
  • Market Ecosystem
  • Market Attractiveness Index, 2024
  • PESTEL Analysis
  • Macro-Economic Indicators
  • Value Chain Analysis
  • Pricing Analysis
  • Technology Analysis
  • Case Studies
  • Customer Buying Behavior Analysis

Global Dental Infection Treatment Market Size by Treatment Type & CAGR (2025-2032)

  • Market Overview
  • Antibiotics
  • Antifungals
  • Antivirals
  • Pain Management
  • Surgical Procedures (Root Canal, Extraction)
  • Topical Medications

Global Dental Infection Treatment Market Size by Infection Type & CAGR (2025-2032)

  • Market Overview
  • Periodontal Infections (Gingivitis, Periodontitis)
  • Endodontic Infections (Pulpitis, Abscesses)
  • Caries-Related Infections
  • Pericoronitis
  • Oral Candidiasis

Global Dental Infection Treatment Market Size by End Users & CAGR (2025-2032)

  • Market Overview
  • Dental Clinics
  • Hospitals
  • Ambulatory Surgical Centres
  • Research & Academic Institutions

Global Dental Infection Treatment Market Size & CAGR (2025-2032)

  • North America (Treatment Type, Infection Type, End Users)
    • US
    • Canada
  • Europe (Treatment Type, Infection Type, End Users)
    • Germany
    • Spain
    • France
    • UK
    • Italy
    • Rest of Europe
  • Asia Pacific (Treatment Type, Infection Type, End Users)
    • China
    • India
    • Japan
    • South Korea
    • Rest of Asia-Pacific
  • Latin America (Treatment Type, Infection Type, End Users)
    • Brazil
    • Rest of Latin America
  • Middle East & Africa (Treatment Type, Infection Type, End Users)
    • GCC Countries
    • South Africa
    • Rest of Middle East & Africa

Competitive Intelligence

  • Top 5 Player Comparison
  • Market Positioning of Key Players, 2024
  • Strategies Adopted by Key Market Players
  • Recent Developments in the Market
  • Company Market Share Analysis, 2024
  • Company Profiles of All Key Players
    • Company Details
    • Product Portfolio Analysis
    • Company's Segmental Share Analysis
    • Revenue Y-O-Y Comparison (2022-2024)

Key Company Profiles

  • Patterson Dental Supply, Inc. (United States)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Johnson & Johnson (United States)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Pfizer Inc. (United States)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Kerr Corporation (United States)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Bristol-Myers Squibb (United States)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Septodont Healthcare India Pvt. Ltd. (India)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Henry Schein, Inc. (United States)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Ultradent Products Inc. (United States)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Endo Pharmaceuticals (United States)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Taj Pharmaceuticals Limited (India)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Daiichi Sankyo (Japan)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Bayer HealthCare (Germany)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Young Innovations, Inc. (United States)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • 3M (United States)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • A-dec Inc. (United States)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Dentsply Sirona Inc. (United States)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • COLTENE Group (Switzerland)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Getinge AB (Sweden)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • GC America Inc. (United States)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments

Conclusion & Recommendations

샘플 요청 목록
0 건의 상품을 선택 중
목록 보기
전체삭제